Clinical trial
Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT)…
NCT00391911 · Royal Alexandra Hospital, Other · Completed
Key facts
| NCT number | NCT00391911 |
|---|---|
| Title | Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis |
| Official title | A Randomized Factorial Trial of N-Acetylcysteine and Continuous Veno-Venous Hemo(Dia)Filtration for Rhabdomyolysis |
| Lead sponsor | Royal Alexandra Hospital, Other |
| Collaborators | University of Alberta Gambro Renal Products, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhabdomyolysis |
| Intervention type | Drug, Other |
| Interventions | N-Acetylcysteine, N-Acetylcystine and Non CRRT, Placebo and CRRT, Placebo and Non CRRT |
| Enrollment | 3 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Oct 25, 2006 |
| Last update posted | Mar 5, 2012 |
| Countries | Canada, Saudi Arabia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: